GENFIT
Develops therapies and diagnostics for patients with rare and severe liver diseases.
GNFT | PA
Overview
Corporate Details
- ISIN(s):
- FR0004163111 (+2 more)
- LEI:
- 969500XPWN2DMZQA5X73
- Country:
- France
- Address:
- 885 AVENUE EUGENE AVINEE, 59120 LOOS
- Website:
- https://www.genfit.com
Description
GENFIT is a biopharmaceutical company dedicated to developing therapeutic and diagnostic solutions for patients with rare and severe liver diseases characterized by high unmet medical needs. The company's primary focus is on Acute-on-Chronic Liver Failure (ACLF) and its associated conditions, such as acute decompensation (AD) and hepatic encephalopathy (HE). Leveraging a scientific heritage of over two decades, GENFIT is a pioneer in liver disease research and development, aiming to improve the lives of patients with these life-threatening conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-06-24 22:10 |
GENFIT obtient un financement non dilutif de 11 millions d’euros sous forme de …
|
French | 129.7 KB | ||
| 2021-06-23 22:10 |
GENFIT présente de nouvelles données sur NIS4® dans la NASH à l’International L…
|
French | 161.5 KB | ||
| 2021-06-23 22:10 |
GENFIT presents new NIS4® data in NASH at the International Liver Congress™ and…
|
English | 188.1 KB | ||
| 2021-06-15 22:10 |
GENFIT : Assemblée Générale Mixte du 15 juin 2021 : Soutien largement majoritai…
|
French | 178.6 KB | ||
| 2021-06-15 22:10 |
GENFIT: June 15, 2021 Combined Shareholders Meeting: Wide support for the reso…
|
English | 154.8 KB | ||
| 2021-05-27 22:10 |
GENFIT Informs its Shareholders of Certain Procedures for the Combined General …
|
English | 146.6 KB | ||
| 2021-05-27 22:10 |
GENFIT informe ses actionnaires sur certaines modalités de l’Assemblée Générale…
|
French | 147.1 KB | ||
| 2021-05-12 22:10 |
GENFIT : Information financière du premier trimestre 2021
|
French | 160.9 KB | ||
| 2021-05-12 22:10 |
GENFIT: Reports First Quarter 2021 Financial Information
|
English | 148.4 KB | ||
| 2021-05-11 22:10 |
GENFIT : mise à jour du portefeuille de produits et lancement de nouveaux progr…
|
French | 161.8 KB | ||
| 2021-05-11 22:10 |
GENFIT Provides Pipeline Update and Launch of New Clinical Programs
|
English | 164.9 KB | ||
| 2021-05-10 22:10 |
GENFIT Annual Combined General Meeting of June 15, 2021 - Availability of Prepa…
|
English | 135.7 KB | ||
| 2021-05-10 22:10 |
GENFIT : Assemblée Générale Mixte du 15 juin 2021 - modalités de mise à disposi…
|
French | 120.9 KB | ||
| 2021-05-03 08:10 |
GENFIT annonce le lancement par Labcorp de NASHNext®, un test de diagnostic non…
|
French | 184.7 KB | ||
| 2021-05-03 08:10 |
GENFIT announces the launch by Labcorp of NASHnext® A Novel Noninvasive Diagnos…
|
English | 178.4 KB |
Automate Your Workflow. Get a real-time feed of all GENFIT filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GENFIT
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GENFIT via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-07-07 | N/A | Other | Buy | 5,300 | 19,488.10 EUR |
| 2023-07-06 | N/A | Other | Buy | 1,100 | 4,048.00 EUR |
| 2023-07-05 | N/A | Other | Buy | 10,000 | 37,061.00 EUR |
| 2023-07-03 | N/A | Other | Buy | 5,300 | 18,769.95 EUR |
Peer Companies
